[1. S. Tamilvanan and S. Benita, The potential of lipid emulsion for ocular delivery of lipophilic drugs, Eur. J. Pharm. Biopharm.58 (2004) 357–368; https://doi.org/10.1016/J.EJPB.2004.03.03310.1016/j.ejpb.2004.03.033]Search in Google Scholar
[2. F. Lallemand, P. Daull, S. Benita, R. Buggage and J.-S. Garrigue, Successfully improving ocular drug delivery using the cationic nanoemulsion, Novasorb, J. Drug Deliv.2012 (2012) 604204; https://doi.org/10.1155/2012/60420410.1155/2012/604204]Search in Google Scholar
[3. L. Gan, J. Wang, M. Jiang, H. Bartlett, D. Ouyang, F. Eperjesi, J. Liu and Y. Gan, Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers, Drug Discov. Today18 (2013) 290–297; https://doi.org/10.1016/J.DRUDIS.2012.10.00510.1016/j.drudis.2012.10.005]Search in Google Scholar
[4. C. Maïssa, M. Guillon, P. Simmons and J. Vehige, Effect of castor oil emulsion eyedrops on tear film composition and stability, Contact Lens Anterior Eye33 (2010) 76–82; https://doi.org/10.1016/j.clae.2009.10.00510.1016/j.clae.2009.10.005]Search in Google Scholar
[5. A. Manosroi, K. Podjanasoonthon and J. Manosroi, Development of novel topical tranexamic acid liposome formulations, Int. J. Pharm.235 (2002) 61–70; https://doi.org/10.1016/S0378-5173(01)00980-210.1016/S0378-5173(01)00980-2]Search in Google Scholar
[6. S. C. de Araújo, A. C. A. de Mattos, H. F. Teixeira, P. M. Z. Coelho, D. L. Nelson and M. C. de Oliveira, Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions, Int. J. Pharm.337 (2007) 307–315; https://doi.org/10.1016/J.IJPHARM.2007.01.00910.1016/j.ijpharm.2007.01.009]Search in Google Scholar
[7. M. Fraga, M. Laux, B. Zandoná, G. R. Santos, C. dos Santos Giuberti, M. C. de Oliveira, U. Matte and H. Ferreira Teixeira, Optimization of stearylamine-based nanoemulsions obtained by spontaneous emulsification process as nucleic acids delivery systems, J. Drug Deliv. Sci. Technol.18 (2008) 398–403; https://doi.org/10.1016/S1773-2247(08)50078-510.1016/S1773-2247(08)50078-5]Search in Google Scholar
[8. S. H. Klang, J. Frucht-Pery, A. Hoffman and S. Benita, Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle, J. Pharm. Pharmacol.46 (1994) 986–993; https://doi.org/10.1111/j.2042-7158.1994.tb03254.x10.1111/j.2042-7158.1994.tb03254.x]Search in Google Scholar
[9. I. A. Sogias, A. C. Williams and V. V Khutoryanskiy, Why is chitosan mucoadhesive?, Biomacro-molecules9 (2008) 1837–1842; https://doi.org/10.1021/bm800276d10.1021/bm800276d]Search in Google Scholar
[10. W. T. Liau and A. M. Kasko, Poly(methyl 6-acryloyl-β-d-glucosaminoside) as a cationic glycomimetic of chitosan, Biomacromolecules18 (2017) 4133–4140; https://doi.org/10.1021/acs.biomac.7b0119110.1021/acs.biomac.7b01191]Search in Google Scholar
[11. M. Juretić, B. Jurišić Dukovski, I. Krtalić, S. Reichl, B. Cetina-Čižmek, J. Filipović-Grčić, J. Lovrić and I. Pepić, HCE-T cell-based permeability model: A well-maintained or a highly variable barrier phenotype?, Eur. J. Pharm. Sci.104 (2017) 23–30; https://doi.org/10.1016/J.EJPS.2017.03.01810.1016/j.ejps.2017.03.018]Search in Google Scholar
[12. M. Juretić, B. Cetina-Čižmek, J. Filipović-Grčić, A. Hafner, J. Lovrić and I. Pepić, Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models, Eur. J. Pharm. Sci.120 (2018) 133–141; https://doi.org/10.1016/J.EJPS.2018.04.03210.1016/j.ejps.2018.04.032]Search in Google Scholar
[13. K. Kinnunen, A. Kauppinen, N. Piippo, A. Koistinen, E. Toropainen and K. Kaarniranta, Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures, Exp. Eye Res.120 (2014) 82–89; https://doi.org/10.1016/J.EXER.2014.01.00610.1016/j.exer.2014.01.006]Search in Google Scholar
[14. A. Pauly, M. Meloni, F. Brignole-Baudouin, J.-M. Warnet and C. Baudouin, Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: Early detection of toxic damage, Invest. Ophthalmol. Vis. Sci.50 (2009) 1644–1652; Retrieved from http://dx.doi.org/10.1167/iovs.08-299210.1167/iovs.08-2992]Search in Google Scholar
[15. I. Pereira de Sousa, C. Steiner, M. Schmutzler, M. D. Wilcox, G. J. Veldhuis, J. P. Pearson, C. W. Huck, W. Salvenmoser and A. Bernkop-Schnürch, Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles, Eur. J. Pharm. Biopharm.97 (2015) 273–279; https://doi.org/10.1016/J.EJPB.2014.12.02410.1016/j.ejpb.2014.12.024]Search in Google Scholar
[16. Y. Singh, J. G. Meher, K. Raval, F. A. Khan, M. Chaurasia, N. K. Jain and M. K. Chourasia, Nanoemulsion: Concepts, development and applications in drug delivery, J. Control. Release252 (2017) 28–49; https://doi.org/10.1016/j.jconrel.2017.03.00810.1016/j.jconrel.2017.03.008]Search in Google Scholar
[17. V. K. Rai, N. Mishra, K. S. Yadav and N. P. Yadav, Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications, J. Control. Release270 (2018) 203–225; https://doi.org/10.1016/J.JCONREL.2017.11.04910.1016/j.jconrel.2017.11.049]Search in Google Scholar
[18. S. M. Đorđević, A. Santrač, N. D. Cekić, B. D. Marković, B. Divović, T. M. Ilić, M. M. Savić and S. D. Savić, Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances, Int. J. Pharm.533 (2017) 421–430; https://doi.org/10.1016/J.IJPHARM.2017.05.05110.1016/j.ijpharm.2017.05.051]Search in Google Scholar
[19. L. Gan, J. Wang, M. Jiang, H. Bartlett, D. Ouyang, F. Eperjesi, J. Liu and Y. Gan, Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers, Drug Discov. Today18 (2013) 290–297; https://doi.org/10.1016/J.DRUDIS.2012.10.00510.1016/j.drudis.2012.10.005]Search in Google Scholar
[20. R. L. Walenga, A. H. Babiskin, X. Zhang, M. Absar, L. Zhao and R. A. Lionberger, Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup Time, J. Pharm. Sci.108 (2019) 620–629; https://doi.org/10.1016/J.XPHS.2018.10.03410.1016/j.xphs.2018.10.034]Search in Google Scholar
[21. H. Qu, J. Wang, Y. Wu, J. Zheng, Y. S. R. Krishnaiah, M. Absar, S. Choi, M. Ashraf, C. N. Cruz and X. Xu, Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: A cyclosporine ophthalmic emulsion case, Int. J. Pharm.538 (2018) 215–222; https://doi.org/10.1016/J.IJPHARM.2018.01.01210.1016/j.ijpharm.2018.01.012]Search in Google Scholar
[22. T. J. Wooster, M. Golding and P. Sanguansri, Impact of Oil Type on Nanoemulsion Formation and Ostwald Ripening Stability, Langmuir24 (2008) 12758–12765; https://doi.org/10.1021/la801685v10.1021/la801685v]Search in Google Scholar
[23. S. Uluata, E. A. Decker and D. J. McClements, Optimization of Nanoemulsion Fabrication Using Microfluidization: Role of Surfactant Concentration on Formation and Stability, Food Biophys.11 (2016) 52–59; https://doi.org/10.1007/s11483-015-9416-110.1007/s11483-015-9416-1]Search in Google Scholar
[24. H. D. Silva, M. A. Cerqueira and A. A. Vicente, Influence of surfactant and processing conditions in the stability of oil-in-water nanoemulsions, J. Food Eng.167 (2015) 89–98; https://doi.org/10.1016/j.jfoodeng.2015.07.03710.1016/j.jfoodeng.2015.07.037]Search in Google Scholar
[25. S. Brösel and H. Schubert, Investigations on the role of surfactants in mechanical emulsification using a high-pressure homogenizer with an orifice valve, Chem. Eng. Process. Process Intensif.38 (1999) 533–540; https://doi.org/10.1016/S0255-2701(99)00050-110.1016/S0255-2701(99)00050-1]Search in Google Scholar
[26. J.-P. Hsu and A. Nacu, Behavior of soybean oil-in-water emulsion stabilized by nonionic surfactant, J. Colloid Interface Sci.259 (2003) 374–381; https://doi.org/10.1016/S0021-9797(02)00207-210.1016/S0021-9797(02)00207-2]Search in Google Scholar
[27. J. M. Tiffany, N. Winter and G. Bliss, Tear film stability and tear surface tension, Curr. Eye Res.8 (1989) 507–515; https://doi.org/10.3109/0271368890900003110.3109/02713688909000031]Search in Google Scholar
[28. B. Nagyová and J. M. Tiffany, Components responsible for the surface tension of human tears, Curr. Eye Res.19 (1999) 4–11; https://doi.org/10.1076/ceyr.19.1.4.534110.1076/ceyr.19.1.4.5341]Search in Google Scholar
[29. A. Puinhas, P. Sampaio, E. M. S. Castanheira, M. E. C. D. Real Oliveira and M. Lira, Comparison of IgA, TNF-α and surface tension of the tear film in two different times of the day, Contact Lens Anterior Eye36 (2013) 140–145; https://doi.org/10.1016/J.CLAE.2012.12.00510.1016/j.clae.2012.12.005]Search in Google Scholar
[30. M. Hotujac Grgurević, M. Juretić, A. Hafner, J. Lovrić and I. Pepić, Tear fluid-eye drops compatibility assessment using surface tension, Drug Dev. Ind. Pharm.43 (2017) 275–282; https://doi.org/10.1080/03639045.2016.123892410.1080/03639045.2016.1238924]Search in Google Scholar
[31. A. Ludwig and H. Reimann, Eye BT – Practical Pharmaceutics: An International Guideline for the Preparation, Care and Use of Medicinal Products, In Y. Bouwman-Boer, V. Fenton-May, & P. Le Brun (Eds.), (pp. 163–188). Cham: Springer International Publishing; https://doi.org/10.1007/978-3-319-15814-3_1010.1007/978-3-319-15814-3_10]Search in Google Scholar
[32. K. A. Fitzgerald, M. Malhotra, C. M. Curtin, F. J. O’ Brien and C. M. O’ Driscoll, Life in 3D is never flat: 3D models to optimise drug delivery, J. Control. Release215 (2015) 39–54; https://doi.org/10.1016/J.JCONREL.2015.07.02010.1016/j.jconrel.2015.07.020]Search in Google Scholar
[33. M. Ruponen and A. Urtti, Undefined role of mucus as a barrier in ocular drug delivery, Eur. J. Pharm. Biopharm.96 (2015) 442–446; https://doi.org/10.1016/J.EJPB.2015.02.03210.1016/j.ejpb.2015.02.032]Search in Google Scholar
[34. I. Pepić, J. Lovrić, B. Cetina-Čižmek, S. Reichl and J. Filipović-Grčić, Toward the practical implementation of eye-related bioavailability prediction models, Drug Discov. Today19 (2014) 31–44; https://doi.org/10.1016/J.DRUDIS.2013.08.00210.1016/j.drudis.2013.08.002]Search in Google Scholar
[35. I. Krtalić, S. Radošević, A. Hafner, M. Grassi, M. Nenadić, B. Cetina-Čižmek, J. Filipović-Grčić, I. Pepić and J. Lovrić, D-Optimal Design in the Development of Rheologically Improved In Situ Forming Ophthalmic Gel, J. Pharm. Sci.107 (2018) 1562–1571; https://doi.org/10.1016/J.XPHS.2018.01.01910.1016/j.xphs.2018.01.019]Search in Google Scholar
[36. J. Bassi da Silva, S. B. de S. Ferreira, O. de Freitas and M. L. Bruschi, A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems, Drug Dev. Ind. Pharm.43 (2017) 1053–1070; https://doi.org/10.1080/03639045.2017.129460010.1080/03639045.2017.1294600]Search in Google Scholar
[37. E. E. Hassan and J. M. Gallo, A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength, Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci. (1990); https://doi.org/10.1023/A:101581261563510.1023/A:1015812615635]Search in Google Scholar